Sunderland man with incurable cancer begins teaching career
Chris Johnson has raised more than £40,000 for charity and says he still wants to help people.
Related Articles
AI is dumber than you think
The top generative AI company, OpenAI, gave leading chatbots an “SAT test.” The chatbots failed miserably.
Patterns of medicine use in the year prior to death by suicide: an Australian population-based case series study
Dispensing of antidepressants and benzodiazepines increased more rapidly closer to date of death, regardless of medicine involvement in death. This suggests these changes may reflect…
With rising cancer rates in younger adults, experts emphasize better tests
Screening procedures like colonoscopies and mammograms are still “vastly underutilized.”
World Antimicrobial Awareness Week 2024
World Antimicrobial Awareness Week aims to increase awareness of global antimicrobial resistance (AMR) and to encourage best practices.
Chinese army unveils robot wolf, the new leader of the AI pack
The Chinese military has unveiled a robot “wolf” that can climb stairs and obey spoken commands, as the robotic arms race gathers pace among the…
Glucose Control: Why Timing Your Exercise After Meals Matters
Your glucose levels spike about 90 minutes after you eat. Find out how timing post-meal exercise can help stabilize blood sugar and lower your heart…
The Hottest Startups in Paris in 2024
The French capital has become the home of Europe’s growing AI industry—but alongside giants like Mistral are startups building EV charging infrastructure and trying to…
Ending a cycle of poverty and protecting our children
Inside Zambia’s Cancer Disease Hospital complex, there’s a small space with 2 containers. They have just been painted in bright teal – a colour that…
Predictions From IEEE’s 2024 Technology Megatrends Report
AI, digital transformation, and sustainability will reshape society
Brookfield mulls $7.4 bln bid for Spain’s Grifols, El Confidencial says
Canadian fund Brookfield plans to offer about 7 billion euros ($7.4 billion) for Spanish drugmaker Grifols after finishing due diligence, news website El Confidencial reported…
